SCHEMBL7913189

SCHEMBL7913189

O=C(Nc1ccc(-c2ccc(C(=O)O)cc2)cc1)OCC1c2ccccc2-c2ccccc21

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.59
KMT2A Q03164 3/20 0.50
MDM2 Q00987 1/20 0.44
FABP7 O15540 2/20 0.43
FABP5 Q01469 2/20 0.43
ALDH1A1 P00352 2/20 0.43
PKM P14618 1/20 0.43
CRHBP P24387 1/20 0.43
RAB9A P51151 1/20 0.43
CRHR2 Q13324 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
MDM4 O15151 1/20 0.43
TP53 P04637 1/20 0.43
CASP3 P42574 2/20 0.43
PTPN1 P18031 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29401210 0.96 EPHX2 (0.63) EPHX2KMT2AFABP7FABP5ALDH1A1
SCHEMBL29561956 0.96 EPHX2 (0.63) EPHX2KMT2AFABP7FABP5ALDH1A1
SCHEMBL118052 0.96 EPHX2 (0.63) EPHX2KMT2AFABP7FABP5ALDH1A1
SCHEMBL3202738 0.90 EPHX2 (0.66) EPHX2KMT2A
SCHEMBL7921985 0.90 EPHX2 (0.60) EPHX2KMT2AMDM2RAB9ASMN1; SMN2
Acetic Acid SCHEMBL1157085 0.89 EPHX2 (0.60) EPHX2KMT2AMDM2FABP7FABP5
SCHEMBL10283985 0.87 EPHX2 (0.56) EPHX2KMT2AMDM2CASP3
SCHEMBL8366872 0.87 EPHX2 (0.75) EPHX2KMT2AFABP7FABP5ALDH1A1
SCHEMBL5189498 0.85 EPHX2 (0.65) EPHX2KMT2AFABP7FABP5RAB9A
SCHEMBL22932201 0.85 EPHX2 (0.65) EPHX2KMT2AFABP7FABP5PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4400505-A1 PEPTIDE-UREA DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND APPLICATION THEREOF Bivision Pharmaceuticals, Inc (CN) 2024-07-17 EP disclosed
US-6228985-B1 COMPOUNDS THAT INHIBIT INTERACTION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR WITH UROKINASE-TYPE PLASMINOGEN RECEPTOR; ANTITUMOR AGENTS; ANTIMETASTASIS AGENTS; ANTIARTHRITIC AGENTS FOR RHEUMATOID ARTHRITIS SCHERING CORPORATION 2001-05-08 US disclosed